The two chromosomes of cholera

suggests that the bacterium's second chromosome may have started life as a megaplasmid.

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In the 3 August Nature, The Institute for Genomic Research (TIGR) has unveiled its twentieth completed bacterial sequence (Heidelberg et al, Nature 2000, 406:477-484). The complete sequence of the cholera-causing bacterium Vibrio cholerae consists of the 2.96 Mbp chromosome 1 and the 1.07 Mbp chromosome 2. Chromosome 1 contains a standard bacterial origin of replication and the vast majority of the bacterium's essential genes, whereas chromosome 2 has an origin of replication and various genes that are usually associated with plasmids, and thus may have started life as a megaplasmid. The two chromosome have, however, coexisted for a long time based on their almost identical G+C content. Moreover, chromosome 2 now has several essential genes, and a number of regulatory proteins control genes on both chromosomes. The bacterium's strategies for coordinating replication and segregation of the two chromosomes remain to be established.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform